{
    "clinical_study": {
        "@rank": "131197", 
        "arm_group": [
            {
                "arm_group_label": "TIVa", 
                "arm_group_type": "Experimental", 
                "description": "flu vaccine"
            }, 
            {
                "arm_group_label": "TIVb", 
                "arm_group_type": "Active Comparator", 
                "description": "flu vaccine"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is designed to evaluate the safety of TIVa or TIVb vaccine in children 3 to < 18\n      years of age who are at risk of complications of influenza disease due to underlying\n      diseases."
        }, 
        "brief_title": "A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Individuals 3 through 17 years of age with underlying medical conditions that\n             indicate an increased risk of complications from influenza infection.\n\n          -  Further eligibility criteria may be discussed by contacting the site(s)\n\n        Exclusion Criteria:\n\n          -  Individuals with any fatal prognosis of an underlying medical condition (<12 month\n             life expectancy).\n\n          -  Individuals hospitalized at the time of enrolment.\n\n          -  Individuals with a history of any anaphylaxis, serious vaccine reactions, or\n             hypersensitivity to any of the vaccine components.\n\n          -  Further eligibility criteria may be discussed by contacting the site(s)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "3 Years"
        }, 
        "enrollment": {
            "#text": "430", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01998477", 
            "org_study_id": "V58P15", 
            "secondary_id": "2013-002080-26"
        }, 
        "intervention": [
            {
                "arm_group_label": "TIVa", 
                "description": "Novartis investigational influenza vaccine", 
                "intervention_name": "TIVa", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "TIVb", 
                "description": "Licensed influenza vaccine", 
                "intervention_name": "TIVb", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Influenza", 
            "Vaccine", 
            "Flu", 
            "Children", 
            "Adolescents"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50139"
                    }, 
                    "name": "Novartis Investigational Site 022"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "zip": "16132"
                    }, 
                    "name": "Novartis Investigational Site 020"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20157"
                    }, 
                    "name": "Novartis Investigational Site 021"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "165"
                    }, 
                    "name": "Novartis Investigational Site 023"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "8916"
                    }, 
                    "name": "Novartis Investigational Site 031"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burriana", 
                        "country": "Spain", 
                        "state": "Castellon", 
                        "zip": "12530"
                    }, 
                    "name": "Novartis Investigational Site 017"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Castellon de la Plana", 
                        "country": "Spain", 
                        "state": "Castellon", 
                        "zip": "12004"
                    }, 
                    "name": "Novartis Investigational Site 016"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marbella", 
                        "country": "Spain", 
                        "state": "Malaga", 
                        "zip": "29603"
                    }, 
                    "name": "Novartis Investigational Site 010"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "L'Eliana", 
                        "country": "Spain", 
                        "state": "Valencia", 
                        "zip": "46183"
                    }, 
                    "name": "Novartis Investigational Site 015"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paiporta", 
                        "country": "Spain", 
                        "state": "Valencia", 
                        "zip": "46200"
                    }, 
                    "name": "Novartis Investigational Site 013"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quart de Poblet", 
                        "country": "Spain", 
                        "state": "Valencia", 
                        "zip": "46930"
                    }, 
                    "name": "Novartis Investigational Site 018"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28050"
                    }, 
                    "name": "Novartis Investigational Site 030"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29011"
                    }, 
                    "name": "Novartis Investigational Site 011"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46017"
                    }, 
                    "name": "Novartis Investigational Site 019"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46024"
                    }, 
                    "name": "Novartis Investigational Site 012"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46020"
                    }, 
                    "name": "Novartis Investigational Site 014"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Italy", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase III, Observer-Blind, Randomized Multicenter Study to Evaluate the Safety of Trivalent Subunit Influenza Vaccines, Produced Either in Mammalian Cell Culture (TIVc) or in Embryonated Eggs (TIV), in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications", 
        "overall_official": {
            "affiliation": "Novartis Vaccines", 
            "last_name": "Novartis Vaccines", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: The Italian Medicines Agency", 
                "Spain: Spanish Agency of Medicines"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Proportions of subjects reporting solicited adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "7 days after each vaccination (administered 4 weeks apart)"
            }, 
            {
                "measure": "Proportions of subjects reporting unsolicited (serious or predefined) adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "over a period of approximately 6 to 7 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01998477"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Vaccines", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}